» Articles » PMID: 30043322

Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter Baumannii

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Acinetobacter baumannii is one of the most challenging pathogens, on account of its predisposition to develop resistance leading to severe, difficult-to-treat infections. As these bacteria are more usually isolated from nosocomial infections, the new therapeutic options are demanded. Antimicrobial peptides (AMPs) are compounds likely to find application in the treatment of A. baumannii. These compounds exhibit a wide spectrum of antimicrobial activity and were found to be effective against biofilm. In this study, eight AMPs, namely aurein 1.2, CAMEL, citropin 1.1., LL-37, omiganan, r-omiganan, pexiganan, and temporin A, were tested for their antimicrobial activity. A reference strain of A. baumannii ATCC 19606 was used. Antimicrobial assays included determination of the minimum inhibitory concentration and the minimum biofilm eradication concentration. Considering the fact that the majority of A. baumannii infections are associated with mechanical ventilation and the use of indwelling devices, the activity against biofilm was assessed on both a polystyrene surface and tracheal tube fragments. In addition, cytotoxicity (HaCaT) was determined and in vitro selectivity index was calculated.

Citing Articles

Secapin: a promising antimicrobial peptide against multidrug-resistant Acinetobacter baumannii.

Sadeghi Rad Z, Farahmand M, Kavousi M GMS Hyg Infect Control. 2024; 19:Doc36.

PMID: 39224503 PMC: 11367255. DOI: 10.3205/dgkh000491.


Design and Evaluation of a Novel Anti-microbial Peptide from Cathelicidin-2: Selectively Active Against .

Fathi F, Ghobeh M, H Shirazi F, Tabarzad M Iran J Pharm Res. 2024; 22(1):e141920.

PMID: 38435443 PMC: 10909124. DOI: 10.5812/ijpr-141920.


GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant .

van Hoek M, Alsaab F, Carpenter A Antibiotics (Basel). 2024; 13(1).

PMID: 38247598 PMC: 10812447. DOI: 10.3390/antibiotics13010039.


The Study of Antistaphylococcal Potential of Omiganan and Retro-Omiganan Under Flow Conditions.

Jaskiewicz M, Neubauer D, Sikora K, Bauer M, Bartoszewska S, Blazewicz I Probiotics Antimicrob Proteins. 2024; .

PMID: 38224448 DOI: 10.1007/s12602-023-10197-w.


Novel Antibacterial Agents SAAP-148 and Halicin Combat Gram-Negative Bacteria Colonizing Catheters.

Bouhrour N, van der Reijden T, Voet M, Schonkeren-Ravensbergen B, Cordfunke R, Drijfhout J Antibiotics (Basel). 2023; 12(12).

PMID: 38136778 PMC: 10741160. DOI: 10.3390/antibiotics12121743.


References
1.
de Freitas L, Lorenzon E, Santos-Filho N, Zago L, Uliana M, de Oliveira K . Antimicrobial Photodynamic therapy enhanced by the peptide aurein 1.2. Sci Rep. 2018; 8(1):4212. PMC: 5844988. DOI: 10.1038/s41598-018-22687-x. View

2.
Feng X, Sambanthamoorthy K, Palys T, Paranavitana C . The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides. 2013; 49:131-7. DOI: 10.1016/j.peptides.2013.09.007. View

3.
Schauber J, Gallo R . Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J Invest Dermatol. 2007; 127(3):510-2. DOI: 10.1038/sj.jid.5700761. View

4.
Boman H . Antibacterial peptides: basic facts and emerging concepts. J Intern Med. 2003; 254(3):197-215. DOI: 10.1046/j.1365-2796.2003.01228.x. View

5.
Kamysz W, Okroj M, Lukasiak J . Novel properties of antimicrobial peptides. Acta Biochim Pol. 2003; 50(2):461-9. View